Citations

Clear

4 citation(s) found for "Kim, Darae".

External assessment of an artificial intelligence-enabled electrocardiogram for aortic stenosis detection
Kim, Darae , Kim, Jihoon, Kim, Eun Kyoung , Park, Sung Ji, Choi, Jin-Oh , Friedman, Paul A. , Oh, Jae K. , Lee, Eunjung , Kim, Jihoon, Kim, Eun Kyoung , Chang, Sung‐A , On, Young Keun , Attia, Zachi I. , Park, Kyoung‐Min

Mayo Clinic

European Heart Journal - Digital Health | July 1, 2025 | Volume: 6 | Issue: 4 | Pages: 656-664

10.1093/ehjdh/ztaf067 | PMID 40703138 Get It

Abstract Aims To assess the performance of an artificial intelligence-enabled electrocardiogram (AI-ECG) algorithm in identifying patients with moderate to severe aortic stenosis (AS) in an Asian cohort from a tertiary care centre. Methods and results We identified a randomly selected patients ≥60 years old who underwent echocardiography and ECG within in 31 days between 2012 and 2021 at the Samsung Medical Center in Korea. Patients with previous cardiac surgery, prosthetic valves, or pacemakers were excluded. The AI-ECG model, originally developed and validated by Mayo Clinic in the USA, was applied without fine-tuning. Performance metrics, including the area under the curve (AUC), sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy, were calculated to compare AI-ECG predictions with TTE-confirmed AS status. Among 5425 patients, 1095 had moderate to severe AS, and 4330 age- and sex-matched patients without AS were included as controls. The AI-ECG model achieved an AUC of 0.85 (95% CI: 0.84–0.87) in detecting moderate to severe AS. Sensitivity, specificity, PPV, NPV, and accuracy were 0.83, 0.65, 0.37, 0.94, and 68.29%, respectively. The model's performance was consistent across various age and sex subgroups, with sensitivity increasing in older patients. Conclusion The AI-ECG model developed in the USA demonstrated comparable performance in detecting moderate to severe AS in an Asian cohort compared with its original validation population. These findings highlight the potential utility of AI-ECG as a non-invasive screening tool for AS across diverse patient populations.
Left atrial reservoir strain as a novel predictor of new-onset atrial fibrillation in light-chain-type cardiac amyloidosis
Choi, You‐Jung , Kim, Darae , Rhee, Tea-Min, Lee, Hyun‐Jung , Park, Jun‐Bean , Lee, Seung‐Pyo , Kim, Yong-Jin , Jeon, Eun‐Seok , Oh, Jae K. , Choi, Jin‐Oh , Kim, Hyung‐Kwan , Jeon, Eun-Seok , Kim, Hyung-Kwan , Rhee, Tea-Min, Chang, Sung‐A

Mayo Clinic

European Heart Journal - Cardiovascular Imaging | January 14, 2023 | Volume: 24 | Issue: 6 | Pages: 751-758

10.1093/ehjci/jeac269 | PMID 36637873 Get It

Abstract Aims To investigate whether left arterial reservoir strain (LASr) could predict new-onset atrial fibrillation (NOAF) in patients with light-chain-type cardiac amyloidosis (ALCA). Methods and results This study enrolled 427 patients with CA from two tertiary centres between 2005 and 2019. LASr was measured using a vendor-independent analysis programme. The primary outcome was NOAF. A total of 287 patients with ALCA were included [median age 63.0 (56.0–70.0) years, 53.3% male]. The median LASr was 13.9% (10.5–20.8%). During the median follow-up of 0.85 years, AF occurred in 34 patients (11.8%). In the receiver operating characteristics curve analysis, the optimal cut-off of LASr for predicting NOAF was 14.4%. Patients with LASr ≤14.4% had a higher risk of NOAF than those with LASr >14.4% (18.1% vs. 5.1%, P < 0.010). In the multivariate analysis adjusting for confounding factors, including left arterial volume index and left ventricular global longitudinal strain (LV-GLS), higher LASr (%) was independently associated with lower risk for NOAF [adjusted hazard ratio (aHR): 0.936, 95% confidence interval (95% CI): 0.879–0.997, P = 0.039]. Furthermore, LASr ≤14.4% was an independent predictor for NOAF (aHR: 3.370, 95% CI: 1.337–8.492, P = 0.010). This remained true after accounting for all-cause death as a competing risk. Compared with Model 1 (LV-GLS) and Model 2 (LV-GLS plus LAVI), Model 3, including LASr showed a better reclassification ability for predicting NOAF (net reclassification index = 0.735, P < 0.001 compared with Model 1; net reclassification index = 0.514, P = 0.003 compared with Model 2). Conclusion LASr was an independent predictor of NOAF in patients with ALCA.
Coronary Microcirculatory Dysfunction and Acute Cellular Rejection After Heart Transplantation
Lee, Joo Myung , Choi, Ki Hong, Choi, Jin‐Oh , Shin, Doosup , Park, Yoonjee , Kim, Juwon, Lee, Seung Hun , Kim, Darae, Yang, Jeong Hoon, Cho, Yang Hyun, Sung, Kiick, Choi, Ji Yeon, Park, Meesoon, Kim, Jung-Sun, Park, Taek Kyu, Gwon, Hyeon-Cheol , Oh, Jae K., Jeon, Eun-Seok, Song, Young Bin , Hahn, Joo‐Yong , Choi, Seung-Hyuk , Gwon, Hyeon-Cheol , Shin, Doosup , Lee, Joo Myung , Choi, Ki Hong, Choi, Jin-Oh , Park, Yoonjee , Kim, Juwon, Lee, Seung Hun , Kim, Darae, Yang, Jeong Hoon, Cho, Yang Hyun, Sung, Kiick, Choi, Ji Yeon, Park, Meesoon, Kim, Jung-Sun, Park, Taek Kyu, Oh, Jae K., Jeon, Eun-Seok

Mayo Clinic

Circulation | September 3, 2021 | Volume: 144 | Issue: 18 | Pages: 1459-1472

10.1161/circulationaha.121.056158 | PMID 34474597 Get It

Background: Acute cellular rejection is a major determinant of mortality and retransplantation after heart transplantation. We sought to evaluate the prognostic implications of coronary microcirculatory dysfunction assessed by index of microcirculatory resistance (IMR) for the risk of acute cellular rejection after heart transplantation. Methods: The present study prospectively enrolled 154 heart transplant recipients who underwent scheduled coronary angiography and invasive coronary physiological assessment 1 month after transplantation. IMR is microcirculatory resistance under maximal hyperemia. By measuring hyperemic mean transit time using 3 injections (4 mL each) of room-temperature saline under maximal hyperemia, IMR was calculated as hyperemic distal coronary pressure×hyperemic mean transit time. The primary end point was biopsy-proven acute cellular rejection of grade ≥2R during 2 years of follow-up after transplantation and was compared by using multivariable Cox proportional hazards regression according to IMR. The incremental prognostic value of IMR, in addition to the model with clinical factors, was evaluated by comparison of C-index, net reclassification index, and integrated discrimination index. Results: The mean age of recipients was 51.2±13.1 years (81.2% male), and the cumulative incidence of acute cellular rejection was 19.0% at 2 years. Patients with acute cellular rejection had significantly higher IMR values at 1 month than those without acute cellular rejection (23.1±8.6 versus 16.8±11.1, P =0.002). IMR was significantly associated with the risk of acute cellular rejection (per 5-U increase: adjusted hazard ratio, 1.18 [95% CI, 1.04–1.34], P =0.011) and the optimal cutoff value of IMR to predict acute cellular rejection was 15. Patients with IMR≥15 showed significantly higher risk of acute cellular rejection than those with IMR<15 (34.4% versus 3.8%; adjusted hazard ratio, 15.3 [95% CI 3.6–65.7], P <0.001). Addition of IMR to clinical variables showed significantly higher discriminant and reclassification ability for risk of acute cellular rejection (C-index 0.87 versus 0.74, P <0.001; net reclassification index 1.05, P <0.001; integrated discrimination index 0.20, P <0.001). Conclusions: Coronary microcirculatory dysfunction assessed by IMR measured early after heart transplantation showed significant association with the risk of acute cellular rejection. In addition to surveillance endomyocardial biopsy, early stratification using IMR could be a clinically useful tool to identify patients at higher risk of future acute cellular rejection after heart transplantation. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02798731.